Abstract-The treatment of Non-Hodgkin's lymphoma (NHL) was revolutionized by the approval of rituximab in 1997. Rituximab is a CD20-directed monoclonal antibody (mAb). Despite the great success of rituximab in the treatment of B-cell NHL, the urgent need is to enhance the efficacy due to the markedly variable patient responses. Hence elucidating the molecular mechanisms of rituximab's anti-cancer effect is of great significance. In the past decade the atomic force microscopy (AFM) has proven to be a powerful tool for characterizing the morphological properties and measuring the physiological interaction forces of single cells and single molecules under native conditions. In this work, the AFM single-molecule force spectroscopy(SMFS) was applied to quantitatively measure the CD20-rituximab binding force on Burkitt's lymphoma patient bone marrow cells. The experimental results will facilitate further investigation of the molecular mechanisms of rituximab's anticancer effect.
With the advancement of research methods in biochemistry and molecular biology, the cellular chemical processes have been gradually clarified. However, detail experimental evidence indicates that the in vitro ensemble measurements in test tubes from traditional biochemistry [1, 2] may not reflect the complete interaction in vivo. The conventional in vitro measurements provide averaged information on large ensembles of molecules from many cells [3, 4] . Undoubtedly the results deduced from the ensemble measurements are correct for depicting the behavior of the ensemble molecules, but on the other hand the ensemble measurements hide the rare events of individual molecules [5] . As opposed to ensemble techniques, single-molecule experiments analyze individual molecules in complex systems and thereby can reveal the events and properties that would otherwise be inaccessible by in vitro methods [6] . Consequently, in order to understand the cellular chemical processes profoundly, the single-molecule experiments are strongly required to elucidate the underlying mechanisms of single molecules. In the past decades various single-molecule techniques has been invented for investigating the physical activities of single cells and single molecules, including atomic force microscopy (AFM) [7, 8] , optical tweezers [9, 10] , magnetic tweezers [11] , and biomembrane force probe (BFP) [12] . Among these techniques, AFM is the unique tool for functional, nanoscale probing and morphometric, high-resolution imaging of processes in live cells [13] . The capability of working in fluids makes it possible to observe the dynamic physiological processes of live cells [14] and native protein molecules [15] with AFM. The application of AFM in life sciences during the past decade has proven that AFM is a powerful versatile single-molecule tool for visualizing the surface morphology of native biological samples and the measuring the fundamental physiological interactions at cell and molecule levels under nearphysiological conditions [16] [17] [18] [19] [20] [21] . Besides imaging the surface morphology of the sample, AFM is also a force probe tool with picoNewton force sensitivity and nanometer accuracy 16 and this makes it suitable to detect forces between single receptorligand pairs where ligands are bound to the AFM tip and the receptors are bound to the support surface [8] .This technology is termed single-molecule force spectroscopy (SMFS) [8] .
In the field of engineered antibodies, one of the most widely studied properties of antibodies is antigen-binding affinity [22] and obtaining higher-affinity antibodies is important for efficient binding to the antigenic target and various in vitro strategies have been optimized to mimic the mammalian in vivo process to improve the antibody affinity [23] . Whether there is an optimal antigen-binding affinity for antibodies remains unexplored and hence empirical approaches are warranted for preclinical optimization of antibody affinity [22] . Consequently, AFM may serve as a useful complementally tool for investigating the binding affinity under near-physiological conditions, adding valuable accessory information for conventional methods. Here the SMFS was applied to investigate the specific binding interaction between CD20 antigen and rituximab on lymphoma patient bone marrow cells.
II.MATERIALS AND METHODS

A. Sample preparation
The patient cells were prepared from the bone marrow of a Burkitt's lymphoma patient whose bone marrow was intruded by lymphoma cells. Poly-L-lysine was used to immobilize cells 978-1-61284-154-0/10/$26.00 © 2010 IEEE onto the glass slide. The poly-L-lysine (0.1%) was diluted with deionized water to one tenth of the original value and then was dropped onto fresh glass slides. These slides were stored at room temperature overnight. The paracentesis needle was used to acquire the bone marrow from the Burkitt's lymphoma patient. The bone marrow was dropped onto the poly-L-lysinecoated glass slides and the 4% formaldehyde was used for fixation. The Raji cell line was grown in flasks in RPMI-1640 culture medium containing 10 % fetal bovine serum under 5%CO2 at 37 .
B. Tip functionalization
The heterobifunctional linker N-hydroxysuccinamidepolyethylene glycol-Maleimide (NHS-PEG-MAL) [24, 25] was used to tether rituximabs onto the AFM tip. This linker has an NHS ester on one end and a MAL ester on the other. The NHS end reacts with amines on the silicon tip, yielding a stable amide bond. The MAL group reacts with a protein thiol resulting in a disulfide linkage between PEG and protein. The tip functionalization process followed an established procedure [26] . The aminopropyltriethoxysilane (APTES) and NNdiisopropylethylamine were used to coat the tip with amino groups in a glass dessicator under argon for 0.5-2 hours. Mix the crosslinker and triethylamine in CHCl 3 and place the NH2-modified tips into this solution for 2-3 hours. Rituximabs were treated with N-Succinimidyl 3-(Acetylthio) propionate (SATP) to form thiol functions. Finally the tips were put in the mixture of SATP-rituximab, hydroxylamine and buffer solution (pH 7.5) for 1 hour. The functionalized tips were stored in PBS at 4 .Rituximabs were obtained from Chinese affiliated hospital of military medical academy of sciences. The NHS-PEG-MAL linker molecules were purchased from JenKem Company (China).The reaction reagents were purchased from SigmaAldrich Company (USA). 
C. Fluorescence microscopy
The RBITC-labeled goat anti-human IgG (secondary antibody) was used for fluorescence experiments to demonstrate the rituximab had been tethered onto the AFM tip. Rituximab binds the CD20 and IgG binds the rituximab. First the functionalized tip was placed into a petri dish in PBS and then the rituximab solution was added and incubated 1 hour. The unbound rituximabs were removed by PBS. Then the RBITC-labeled goat anti-human IgG solution was added and incubated 1 hour. After the reaction the functionalized tip was washed with PBS to remove the unbound IgG and placed onto the stage of the fluorescence microscope. The green excitation light was used. The secondary antibody fluorescence labeling of patient cell sample was the same as the above procedure.
D. AFM imaging and measurements
AFM imaging and measurements were performed using a Nanoscope VI Dimension 3100 AFM (Veeco company) and oxide-sharpened Si 3 N 4 tips (type: DNP-S with a radius of 10-40 nm). The largest triangular cantilever with a normal spring constant 0.06N/m (205 ȝm long and 25 ȝm wide) from a set of four on the cantilever chip was used in our measurements. The spring constant was calibrated using a Thermal Tune Adapter (Veeco Company). The probe was localized onto the cell surface with the assistance of a charge-coupled device (CCD) camera. Topographical and deflection images of bone marrow cells were acquired with contact mode at room temperature in air. The scan rate was 1 Hz, and the scan force was 50 pN.
The CD20-rituximab binding force measurement experiment was as followed. First, the functionalized tip was used to acquire force curves on bone marrow cells. If there were abrupt peaks in the retracting curve, this indicated that there were CD20s on the cell surface and then 50 force curves were obtained on this cell at the same loading rate. Tens of cells were randomly selected to quantitatively measure the CD20-rituximab binding force. The blocking experiment 16 was used to demonstrate the specificity of CD20-rituximab binding force. The rituximab solution was added to bind the CD20 sites on the cell surface and after 30 minutes the functionalized tip was used again to obtain the force curves on cell surface. 
III.RESULTS AND DISCUSSION
To measure the CD20-rituximab binding force of lymphoma patient cells, the sample was obtained from the bone marrow of a Burkitt's lymphoma patient whose bone marrow was intruded by lymphoma cells. The AFM images of lymphoma patient bone marrow cells were shown in Fig. 2 . The height image, deflection image and three-dimentional image were shown in Fig. 2A, Fig. 2B, and Fig. 2C respectively. The bone marrow is a central immune organ and contains various cells including red blood cells, white blood cells, and platelets. Once the lymphoma B cells intruded the bone marrow, there were lymphoma B cells in the bone marrow. We can see that the cell surfaces from the bone marrow were smooth. To measure the distribution of cell diameters, eighty cells were randomly selected. According to the Gaussion fitting, the cell diameter was 8.01 1.71ȝm(mean s.d.) (Fig. 2D) . In order to demonstrate that rituximabs had been tethered onto the AFM tip by the functionalization procedure, the scanning electron microscopy (SEM) and fluorescence microscopy (FM) were used (Fig. 3) . The SEM images of the normal tip were shown in Fig.3A , B and the SEM images of the functionalized tip were shown in Fig. 3C, D. Fig.3B was a local area of Fig. 3A and Fig. 3D was a local area of Fig. 3C . From the SEM images of the functionalized tip, we can see that there were many particles with the diameter around 50 nm on the surface of the functionalized tip and this was consistent with the others' results [27] . From the SEM images of the normal tip, we can see that the surface was very smooth. The optical images of the normal tip and the functionalized tip were shown in Fig. 3E and Fig. 3G , respectively. Fluorescence images of the normal tip and the functionalized tip were shown in Fig.3F and Fig. 3H , respectively. From the fluorescence image of the functionalized tip, the fluorescence around the local area of the tip (denoted by white circle in Fig. 3H ) was obviously brighter than other areas, while the fluorescence of the normal tip was dim and uniform. Hence the results of the SEM and FM demonstration experiments indicated that rituximabs were tethered onto the AFM tip.
When the specific binding event occurred, there were one or more distinct abrupt peaks in the retracting portion of the force curve (Fig.4A) . After adding the free antibodies solution to bind to the CD20 sites on the cell surface, no distinct abrupt peaks appeared in the retracting curve (Fig.4B) .The histogram of the binding forces computed from these force curves was shown (Fig.4C) . From the Gaussian fitting we found the binding force was about 180 90pN. Considering several CD20-rituximab bonds might rupture at the same time, the Poisson analysis method [28] was used to compute the single CD20-rituximab binding force. For Poisson analysis, six groups of force curves from six cells were chosen to compute the single CD20-rituximab binding force. Each group contained around 50 force curves at the same loading rate (0.09 10 6 pN/s). We can compute the mean force and variance for each group and then plot the mean force and variance and fit them. The slope of the fitting line was 0.126 and this indicates that the single CD20-rituximab binding force is 126 pN (Fig.4D) .
Using AFM single-molecule force spectroscopy to measure the binding force between receptors and ligands has been discussed for more than ten years and great progress has been made. A wide range of receptor-ligands had been investigated [16, 17, 25, 26, 29] , and these results aided understanding of the molecular dynamics of the receptor-ligand complexes during the association and dissociation processes [16] . Recent researches of single-chain fragment variable (scFv) indicate that the binding force between CD20 and anti-CD20 antibody is closely related to the linker peptide [30] .The rupture force of receptor-ligand interactions is ~20-200pN [8] and it can be varied by changing the spring constant of the cantilever or by changing the retraction speed [16] . To improve the force measuring resolution, cantilever with small spring constant can be used [16] .
In summary, the clinical experiences of rituximab has provided a wealth of data of therapeutic efficacy since 1997 and boosted the advancement of mAb. However, the antibodybased therapy is merely at the dawn [31] . The markedly variable responses of patients strongly require the more potent mAb drugs. Accounting for the individual molecular activities of the mAb is of great importance for revealing the underlying mechanism of the different responses. The efforts in the past decade indicated that AFM is a suitable and powerful tool for characterizing the behavior of single cells and single molecules under near-physiological conditions, revealing the information of single cells and single molecules which was hidden with in vitro measurements. In this paper, using SMFS to investigate the CD20-rituximab binding force directly on lymphoma patient bone marrow cells was preliminarily explored and the results will facilitate further investigation of the variable efficacies of different lymphoma patients.
